Skip to main content

Sangamo Therapeutics, Inc

SGMOQ
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001001233

No open-market purchases or sales by Sangamo Therapeutics, Inc insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $29.0K in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Sangamo Therapeutics, Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
131
+4 vs. Q4 2023
Shares held
101.0M
+14.2M (+16.4%) vs. Q4 2023
Total value
$68.2M
+$21.1M (+44.8%) vs. Q4 2023
New holders
21
30 more added
Sold out
17
50 more reduced

3 institutions that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SGMOQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 131 institutions
Q1 2021: 203 institutionsQ2 2021: 197 institutionsQ3 2021: 193 institutionsQ4 2021: 193 institutionsQ1 2022: 195 institutionsQ2 2022: 188 institutionsQ3 2022: 197 institutionsQ4 2022: 182 institutionsQ1 2023: 180 institutionsQ2 2023: 152 institutionsQ3 2023: 135 institutionsQ4 2023: 130 institutionsQ1 2024: 131 institutionsQ2 2024: 129 institutionsQ3 2024: 103 institutionsQ4 2024: 128 institutionsQ1 2025: 122 institutionsQ2 2025: 114 institutionsQ3 2025: 112 institutionsQ4 2025: 105 institutionsQ1 2026: 112 institutionsQ2 2026: 6 institutions
Value heldQ1 2024: $68.2M
Q1 2021: $994.7MQ2 2021: $912.0MQ3 2021: $679.3MQ4 2021: $577.0MQ1 2022: $459.6MQ2 2022: $371.1MQ3 2022: $477.2MQ4 2022: $326.0MQ1 2023: $197.6MQ2 2023: $137.4MQ3 2023: $61.3MQ4 2023: $47.2MQ1 2024: $68.2MQ2 2024: $31.1MQ3 2024: $48.6MQ4 2024: $62.9MQ1 2025: $34.5MQ2 2025: $39.6MQ3 2025: $42.1MQ4 2025: $26.2MQ1 2026: $26.0MQ2 2026: $29.0K
Institutions holding SGMOQ and their total value by quarter
QuarterHoldersValue
Q2 20266$29.0K
Q1 2026112$26.0M
Q4 2025105$26.2M
Q3 2025112$42.1M
Q2 2025114$39.6M
Q1 2025122$34.5M
Q4 2024128$62.9M
Q3 2024103$48.6M
Q2 2024129$31.1M
Q1 2024131$68.2M
Q4 2023130$47.2M
Q3 2023135$61.3M
Q2 2023152$137.4M
Q1 2023180$197.6M
Q4 2022182$326.0M
Q3 2022197$477.2M
Q2 2022188$371.1M
Q1 2022195$459.6M
Q4 2021193$577.0M
Q3 2021193$679.3M
Q2 2021197$912.0M
Q1 2021203$994.7M

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Sangamo Therapeutics, Inc; share changes are against Q4 2023.

Institutions holding SGMOQ in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Tudor Investment Corp Et Al363,490$243.6K0.00%00.0%Unchanged
Gsa Capital Partners LLP364,284$244.0K0.02%−711,406−66.1%Reduced
Marshall Wace, LLP368,743$247.1K0.00%+368,743New
Macquarie Group Ltd400,000$268.0K0.00%00.0%Unchanged
FMR LLC436,655$292.6K0.00%+125,123+40.2%Added
Schonfeld Strategic Advisors LLC445,300$298.4K0.00%+445,300New
Bank of New York Mellon Corp473,112$317.1K0.00%−23,276−4.7%Reduced
Morgan Stanley534,071$357.9K0.00%−374,935−41.2%Reduced
Dimensional Fund Advisors LP552,879$370.5K0.00%−22,186−3.9%Reduced
Two Sigma Investments, LP554,855$371.9K0.00%−1,619,278−74.5%Reduced
Goldman Sachs Group Inc632,628$424.0K0.00%+372,943+143.6%Added
Zacks Investment Management708,168$474.6K0.01%+157,564+28.6%Added
HighTower Advisors, LLC788,290$489.0K0.00%−2,920−0.4%Reduced
Nuveen Asset Management, LLC737,464$494.2K0.00%00.0%Unchanged
Long Focus Capital Management, LLC1,098,000$735.9K0.08%−274,000−20.0%Reduced
Millennium Management LLC1,104,877$740.5K0.00%−17,722−1.6%Reduced
Northern Trust Corp1,228,885$823.6K0.00%−37,931−3.0%Reduced
Charles Schwab Investment Management Inc1,242,131$832.5K0.00%+35,252+2.9%Added
Mirae Asset Global Investments Co., Ltd.493,431$838.8K0.00%+493,431New
JPMorgan Chase & Co1,322,548$886.4K0.00%−50,727−3.7%Reduced
Hudson Bay Capital Management LP1,373,500$920.5K0.01%−1,126,500−45.1%Reduced
Two Sigma Advisers, LP1,428,255$957.2K0.00%−657,000−31.5%Reduced
Renaissance Technologies LLC2,597,977$1.74M0.00%−547,901−17.4%Reduced
State Street Corp2,751,804$1.84M0.00%+43,436+1.6%Added
D. E. Shaw & Co., Inc.3,067,435$2.06M0.00%−1,616,538−34.5%Reduced
Geode Capital Management, LLC3,363,791$2.25M0.00%+157,481+4.9%Added
Acadian Asset Management LLC4,943,260$3.31M0.01%+192,385+4.0%Added
Vanguard Group Inc12,200,368$8.18M0.00%−398,761−3.2%Reduced
BlackRock Inc.13,277,637$8.90M0.00%−818,228−5.8%Reduced
Armistice Capital, LLC16,958,477$11.4M0.30%+16,958,477New
Wasatch Advisors Inc20,132,324$13.5M0.07%+7,734,400+62.4%Added
Assenagon Asset Management S.A.0$00.00%−1,033,322−100.0%Sold out
HRT Financial LP0$00.00%−72,177−100.0%Sold out
Wexford Capital LP0$00.00%−45,450−100.0%Sold out
Wedmont Private Capital0$00.00%−46,907−100.0%Sold out
Squarepoint Ops LLC0$00.00%−41,146−100.0%Sold out
Franklin Resources Inc0$00.00%−32,786−100.0%Sold out
Tocqueville Asset Management L.P.0$00.00%−14,380−100.0%Sold out
GTS Securities LLC0$00.00%−12,633−100.0%Sold out
Aptus Capital Advisors, LLC0$00.00%−10,000−100.0%Sold out
Guardian Wealth Advisors, LLC0$00.00%−10,000−100.0%Sold out
Tradition Wealth Management, LLC0$00.00%−7,199−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−4,533−100.0%Sold out
Raleigh Capital Management Inc.0$00.00%−4,519−100.0%Sold out
Advisory Services Network, LLC0$00.00%−1,399−100.0%Sold out
TD Waterhouse Canada Inc.0$00.00%−1,031−100.0%Sold out
Planned Solutions, Inc.0$00.00%−300−100.0%Sold out
Guardian Wealth Management, Inc.0$00.00%−230−100.0%Sold out
Golden State Equity Partners––––Not filed
Baystate Wealth Management LLC––––Not filed
Coppell Advisory Solutions LLC––––Not filed